We tested the effects of MEDS-23 on levels of the inflammatory mediators IL-6 and TNF-α in brains of post-stroke rats to elucidate a possible association between its antipyretic effect and its correlation with neuro-inflammation. Here, IL6 is linked to stroke disorder.